IHD: Emerging Markets Equities CEF
seekingalpha.com
Want to monitor CSL?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor CSLCSL Limited is a leading Australian multinational biotechnology company specializing in the research, development, manufacturing, and marketing of lifesaving medicines and vaccines. The company’s portfolio includes plasma-derived therapies for conditions such as hemophilia and immune deficiencies, influenza vaccines, and treatments for rare and serious diseases. CSL operates globally through its core divisions—CSL Behring, CSL Seqirus, and CSL Vifor—serving patients in over 100 countries.